Michael A. Schwarzschild, M.D., Ph.D.
Title Julieanne Dorn Professor of Neurology Institution Massachusetts General Hospital Address Massachusetts General Hospital MassGeneral Inst. for Neurodegenerative Disease-Rm 3002 114 16th Street Charlestown MA 02129
|
|
Biography
1985
Markey Fellowship award, HMS
1987 - 1988
Ryan Fellowship award, HMS
1994 - 1999
Clinical Investigator Development Award, NIH
1999 - 2002
George C. Cotzias Memorial Fellowship Award, APDA
2001
Fox Foundation inaugural research grant program award
Awardee
2002 - 2005
Paul Beeson Faculty Scholar in Aging Research Program awardee, AFAR
2005 - 2006
Dorothy Dillon Eweson Lectureships, AFAR
2006
Partners in Excellence Award (mentoring)
2012 - 2018
Elected Chair, Executive Committee, Parkinson Study Group
2013
Member, Linked Clinical Trials Committee, Cure Parkinson's Trust
2018 - 2024
Elected Chair, Executive Committee, Parkinson Study Group
2017 - 2019
Scientific Advisory Board member, Michael J. Fox Foundation for Parkinson's Research
Overview
Research
The research activities and funding listed below are automatically derived from
NIH ExPORTER and other sources, which might result in incorrect or missing items.
Faculty can
login
to make corrections and additions.
-
R13FD008015
(SCHWARZSCHILD, MICHAEL A)
Jul 15, 2023 - Jun 30, 2028
Planning for Prevention of Parkinson's Disease: a trial design forum
Role: Principal Investigator
-
R01NS110879
(SCHWARZSCHILD, MICHAEL A)
Aug 1, 2019 - May 31, 2024
Urate-LRRK2 interactions in Parkinson's disease
Role: Principal Investigator
-
R13NS111953
(SCHWARZSCHILD, MICHAEL A)
Apr 1, 2019 - Mar 31, 2022
2019 Parkinson Study Group Symposium and Training
Role: Principal Investigator
-
U01NS107009
(DORSEY, EARL RAY;OMBERG, LARSSON G;SCHWARZSCHILD, MICHAEL A ;SIMUNI, TANYA)
Jul 1, 2018 - Apr 30, 2024
Tele-Health Extension for Phase 3 Parkinson's Disease Trial Cohorts
Role: Principal Investigator
-
U13NS103523
(SCHWARZSCHILD, MICHAEL A)
Jul 1, 2017 - Jun 30, 2018
2017 Parkinson Study Group Symposium and Training
Role: Principal Investigator
-
R13NS098746
(SCHWARZSCHILD, MICHAEL A)
Aug 1, 2016 - Jul 31, 2017
2016 Parkinson Study Group Symposium and Training
Role: Principal Investigator
-
(Michael Schwarzschild)
Jan 1, 2016 - Dec 31, 2019
Michael J. Fox Foundation
Blood Sampling for Future Biomarker Research
-
U01NS090259
(SCHWARZSCHILD, MICHAEL A)
Sep 1, 2015 - Jun 30, 2020
Phase 3 trial of inosine for Parkinson's disease CCC
Role: Principal Investigator
-
(Michael Schwarzschild)
Nov 1, 2014 - Oct 31, 2017
Preclinical Foundation of Urate-Elevating Therapy for ALS
Role: Principal Investigator
-
R13NS090879
(SCHWARZSCHILD, MICHAEL A)
Sep 22, 2014 - Aug 31, 2015
2014 Parkinson Study Group Symposium and Training
Role: Principal Investigator
-
(Michael Schwarzschild)
Jun 14, 2014 - Jul 12, 2017
Michael J. Fox Foundation
Purine Biomarkers of LRRK2 PD
-
R13NS086328
(SCHWARZSCHILD, MICHAEL A)
Sep 23, 2013 - Aug 31, 2014
2013 Parkinson's Study Group Symposium
Role: Principal Investigator
-
PDF-APT-1407
(Michael Schwarzschild)
Jul 1, 2013 - Jun 30, 2017
Parkinson’s Disease Foundation
Parkinson Study Group (PSG) -- PDF’s Advancing Parkinson’s Therapies Innovations award
-
R21NS084710
(SCHWARZSCHILD, MICHAEL A)
Jul 1, 2013 - Jun 30, 2015
Role of urate in protecting mitochondrial function in the brain
Role: Principal Investigator
-
R21NS058324
(SCHWARZSCHILD, MICHAEL A)
Jun 15, 2009 - May 31, 2011
Uric Acid:novel therapeutic target for Parkinson's Disease
Role: Principal Investigator
-
K24NS060991
(SCHWARZSCHILD, MICHAEL A)
Sep 3, 2008 - Feb 28, 2014
Pursuing purine pathways to clinical trials for Parkinson's disease
Role: Principal Investigator
-
R13NS055597
(SCHWARZSCHILD, MICHAEL A)
Apr 3, 2006 - Mar 31, 2007
Targeting Adenosine A2A Receptors in Parkinson's Disease
Role: Principal Investigator
-
R01NS054978
(SCHWARZSCHILD, MICHAEL A)
Apr 1, 2006 - Mar 31, 2012
Translational Foundation of Adenosine Antagonist Use for Dyskinesias
Role: Principal Investigator
-
R13NS044990
(SCHWARZSCHILD, MICHAEL A)
Sep 1, 2002 - Aug 31, 2003
Translating A2A Receptor Biology into Novel PD Therapy
Role: Principal Investigator
-
R01DA013508
(SCHWARZSCHILD, MICHAEL A)
Jul 25, 2001 - May 31, 2006
A2A Adenosine Receptors in Psychostimulant Sensitization
Role: Principal Investigator
-
R01ES010804
(SCHWARZSCHILD, MICHAEL A)
May 1, 2001 - Apr 30, 2006
Novel Neuroprotection by Caffeine in Parkinson's Disease
Role: Principal Investigator
-
R03AG018167
(SCHWARZSCHILD, MICHAEL A)
Sep 1, 2000 - Aug 31, 2001
A2A ADENOSINE RECEPTOR--A NOVEL ROLE IN NEUROPROTECTION
Role: Principal Investigator
-
K08NS001729
(SCHWARZSCHILD, MICHAEL A)
Jul 1, 1994 - Jun 30, 1999
RAS AND NEURONAL GENE REGULATION BY CNTF
Role: Principal Investigator
-
R01DA007496
(SCHWARZSCHILD, MICHAEL A)
Aug 1, 1992 - Aug 31, 2001
ADENOSINE A2 RECEPTORS AND PSYCHOSTIMULANT INTERACTIONS
Role: Principal Investigator
-
M01RR001066
(SLAVIN, PETER L)
Feb 1, 1978 - May 31, 2008
General Clinical Research Center
Role: Co-Principal Investigator
Featured Content
Bibliographic
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.